{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:56:29Z","timestamp":1791050189161,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["PI043296"],"award-info":[{"award-number":["PI043296"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AC14\/00016"],"award-info":[{"award-number":["AC14\/00016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/302"],"award-info":[{"award-number":["PI14\/302"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00096"],"award-info":[{"award-number":["PI17\/00096"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI043760"],"award-info":[{"award-number":["PI043760"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["Exp 2017 SGR 1502"],"award-info":[{"award-number":["Exp 2017 SGR 1502"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.parkreldis.2019.05.040","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T13:33:33Z","timestamp":1559568813000},"page":"3-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study"],"prefix":"10.1016","volume":"65","author":[{"given":"Yaroslau","family":"Compta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-4840","authenticated-orcid":false,"given":"Sara P.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darly M.","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"P\u00e9rez-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Saura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pulido-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7027-3093","authenticated-orcid":false,"given":"C\u00e8lia","family":"Painous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-704X","authenticated-orcid":false,"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Valldeoriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Hern\u00e1ndez-Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge Jauma","family":"Classen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claustre","family":"Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Caballol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angels","family":"Bayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-7601","authenticated-orcid":false,"given":"Jaume","family":"Campdelacreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"de F\u00e0bregues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Calopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Gaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Fabregat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2573-6378","authenticated-orcid":false,"given":"Pau","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Planellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ezquerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Fern\u00e1ndez-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.05.040_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"\u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder","volume":"74","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10072-016-2783-7","article-title":"Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis","volume":"38","author":"Hu","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib6","doi-asserted-by":"crossref","first-page":"e0147574","DOI":"10.1371\/journal.pone.0147574","article-title":"Serum levels of coenzyme Q10 in patients with multiple system Atrophy","volume":"11","author":"Kasai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamaneurol.2016.1325","article-title":"Plasma coenzyme Q10 levels in patients with multiple system atrophy","volume":"73","author":"Mitsui","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.parkreldis.2017.10.010","article-title":"Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy","volume":"46","author":"Compta","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib10","doi-asserted-by":"crossref","first-page":"e62354","DOI":"10.1371\/journal.pone.0062354","article-title":"Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy","volume":"8","author":"Kaufman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-017-0863-0","article-title":"Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine\/chemokine profiles: a case control study","volume":"14","author":"Yamasaki","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib13","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","article-title":"Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease","volume":"24","author":"Compta","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib14","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Multiple system Atrophy study group. Development and validation of the unified multiple system Atrophy rating Scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib15","series-title":"Recent Developments in Parkinson's Disease","first-page":"153","article-title":"Members of the UPDRS development committee, unified Parkinson's disease rating Scale","author":"Fahn","year":"1987"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"onset, progression, and mortality Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/brain\/awf084","article-title":"Force overflow and levodopa-induced dyskinesias in Parkinson's disease","volume":"125","author":"Wenzelburger","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib19","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy","volume":"22","author":"Stefanova","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib20","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.yexcr.2008.02.019","article-title":"The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons","volume":"314","author":"Edman","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1189\/jlb.0810442","article-title":"CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function","volume":"89","author":"Dogan","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","article-title":"Balancing the immune response in the brain: IL-10 and its regulation","volume":"13","author":"Lobo-Silva","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0404.2008.01103.x","article-title":"Circulating interleukin-10 and interleukin-12 in Parkinson's disease","volume":"119","author":"Rentzos","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.STR.0000057976.53301.69","article-title":"Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke","volume":"34","author":"Vila","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1471-4159.2003.01574.x","article-title":"Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons","volume":"84","author":"Rideout","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0006-8993(00)02900-0","article-title":"Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine","volume":"883","author":"Shults","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib27","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3389\/fneur.2018.01123","article-title":"Serum inflammatory profile for the discrimination of clinical subtypes in Parkinson's disease","volume":"9","author":"Yilmaz R","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/nyas.12805","article-title":"Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?","volume":"1351","author":"Lauro","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib30","doi-asserted-by":"crossref","first-page":"14592","DOI":"10.1523\/JNEUROSCI.0539-12.2012","article-title":"The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease","volume":"32","author":"Morganti","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-8-9","article-title":"CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease","volume":"8","author":"Pabon","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.parkreldis.2019.05.040_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fneur.2015.00091","article-title":"CSF neurofilament light chain but not FLT3 ligand discriminates parkinsonian disorders","volume":"6","author":"Herbert","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/mds.25948","article-title":"Flt3 ligand does not differentiate between Parkinsonian disorders","volume":"29","author":"Silajd\u017ei\u0107","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.05.040_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","article-title":"Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies","volume":"6","author":"Refolo","year":"2018","journal-title":"Acta Neuropathol. Commun."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:13:33Z","timestamp":1762370013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019302615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"alternative-id":["S1353802019302615"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.040","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}